Gene Query: NR4A3

Dataset Description Geneva Score
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 252.17
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 198.9
PGE2 mediated gene expression changes in human cervical stromal cells 173.14
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 168.04
A549 cell transcriptome responses to infection with H7N9 influenza virus 154.98
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 150.85
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 150.85
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 147.9
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 136.59
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 136.59
Gene Expression Profiling of WT and KDM3A Knocked out Cell 98.31
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 98.31
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 98.23
Transcriptomic profiling of human peripheral blood-derived mast cells 98.23
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 95.0
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 93.41
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 85.15
RNA-seq analysis of uveal melanoma cells treated with FR900359 84.03
EWSR1 influences alternative splicing through direct and indirect mechanisms 75.74
Transcriptome analysis in Neobractatin treated cells 67.99
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 66.32
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 66.32
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 66.01
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 65.96
RNA sequencing of GlyH-101-treated MCF-7 cell line 65.56
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 59.1
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 57.88
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 55.84
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 53.48
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 49.86
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 49.49
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 49.49
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 49.19
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 47.82
Gene expression changes upon drug withdrawal (Mel888 cell line) 47.81
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 47.74
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 46.75
A Unique Epigenomic Landscape Defines Human Erythropoiesis 46.75
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 45.76
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 42.72
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 41.07
Human neutrophil genome during PMA- and E. coli encounter-induced activation 41.0
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 41.0
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 40.78
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 40.35
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 38.79
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 38.79
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 38.09
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 33.61
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 32.85
Gene expression activation in CLL mediated by MSCs contact 32.78
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 32.55
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 32.53
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 31.6
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 31.06
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 30.56
Generation and functional characterization of MDSC-like cells 30.52
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 30.07
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 27.96
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 27.33
Fibroblasts in cholesteatoma activate osteoclasts. 27.19
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 27.17
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 26.87
RNA-sequencing of human tendon after injury 26.83
Regulation of Lipids is Central to Replicative Senescence 26.81
Cell responses to dysregulated VZV-induced cell-cell fusion 26.56
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 26.5
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 25.72
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 25.47
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 25.47
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 25.47
A novel target of EZH1/2 for treatment of mantle cell lymphoma 25.46
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 25.24
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 25.19
Transcriptomic analysis of human tonsillar TFH subsets 25.08
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 24.8
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 24.68
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 24.63
Activity-dependent transcriptional changes in human neurons 24.32
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 24.24
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 24.06
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 23.98
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 23.96
Transcriptomes of human monocytes after ex vivo exposure to uric acid 23.9
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 23.7
Intron retention induced by microsatellite expansions as a disease biomarker. 23.12
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 22.96
Nutritional control of protein translation 22.56
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 22.36
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 22.36
RNA-seq analysis of the human fetal kidney. 22.22
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 22.0
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 21.94
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 21.9
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 21.89
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 21.74
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 21.74
X-Ray induced DNA-Hydroxymethylation changes 21.6
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 20.88
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 20.49
Transcriptomes of oxLDL exposed trained monocytes 20.47
oxLDL exposed trained monocytes 20.47
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 20.46
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 20.37
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 20.31
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 20.31
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 20.3
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 20.19
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 19.86
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 19.66
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 19.24
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 18.95
The expression profiles of GBC liver metastasis 18.81
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 18.65
Macrophage Ad5f35 PhenoMap 18.4
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 18.3
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 18.3
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 17.81
Macrophage Ad5f35 M2 Challenge 17.51
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 17.51
Intrahepatic MAIT cell gene expression revealed by RNA-seq 17.46
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 17.16
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 17.16
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 17.13
NAPRT activation of macrophages 16.91
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 16.91
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 16.57
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 16.54
Identification of global regulators of T-helper cell lineage specification 16.51
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 16.51
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 16.29
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 16.26
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 16.17
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 16.14
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 16.14
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 16.13
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 16.08
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 16.04
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 15.96
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 15.77
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 15.75
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 15.67
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 15.64
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 15.64
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 15.61
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 15.6
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 15.58
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 15.58
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 15.26
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 15.26
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 15.15
Transcriptome of activated human and mouse MAIT cells 14.95
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 14.95
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 14.81
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 14.81
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 14.68
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 14.66
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 14.58
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 14.58
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 14.47
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 14.43
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 14.23
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 14.12
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 13.69
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 13.61
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 13.61
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 13.57
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 13.51
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 13.5
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 13.45
Primary Human B-cell Temporal Response to CD40L Stimulation 13.43
Impact of dieldrin on transcription in Jurkat T cells 13.29
Genome-wide identification of cancer-specific alternative splicing in circRNA 13.22
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 13.11
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 13.11
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 12.88
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 12.76
Argonaute proteins couple chromatin silencing to alternative splicing 12.66
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 12.66
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 12.65
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 12.51
mRNA-sequencing of breast cancer subtypes and normal tissue 12.48
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 12.29
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 11.91
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 11.87
The role of CFTR in islet function 11.85
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 11.85
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 11.85
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 11.85
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 11.82
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 11.54
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 11.5
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 11.5
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 11.45
circRNA-sequencing 11.37
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 10.98
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 10.92
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 10.63
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 10.59
Gene expression alterations of pancreatic intraepithlial neoplasia 10.47
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 10.45
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 10.45
Endometrial transcriptome and PGR cistrome in cycling fertile women 10.45
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 10.4
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 10.37
Short and Long RNA sequencing of human mature erythrocytes 10.35
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 10.32
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 10.2
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 10.16
Evaluating pre-clinical models for studying NASH driven HCC. 10.12
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 10.09
Morphological and molecular characterization of human dermal lymphatic collectors 10.01
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 9.99
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 9.99
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 9.91
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 9.79
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 9.79
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 9.7
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 9.7
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 9.63
A role for ZNF598 in post-transcriptional gene regulation 9.63
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 9.47
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 9.38
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 9.37
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 9.37
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 9.33
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 9.33
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 9.31
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 9.3
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 9.24
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 9.24
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 9.14
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 9.14
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 9.14
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 9.06
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 9.03
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 8.98
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 8.91
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 8.83
Noncoding regions are the main source of targetable tumor-specific antigens 8.76
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 8.72
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 8.68
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 8.49
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 8.48
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 8.21
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 8.21
Stem and effector CD8 T-cells from human cancers 8.21
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 8.19
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 8.19
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 8.13
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 8.11
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 8.1
Enhancer activation during EGF response 8.05
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 8.02
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 7.98
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 7.9
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 7.64
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 7.64
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 7.56
Conservative alteration of chromosomal expression pattern across human solid tumor types 7.54
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 7.53
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 7.44
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 7.42
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 7.35
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 7.35
Widespread intronic polyadenylation diversifies immune cell transcriptomes 7.35
IDH3a KO RNA-seq 7.33
The transcriptome of Kawasaki Disease arteritis 7.32
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 7.26
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 7.22
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 7.22
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 7.21
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 7.21
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 7.2
Polarized B -cell functions 7.17
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 7.13
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 7.04
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 7.03
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 7.03
CircRNAome diversity in human mature B-cells, T-cells and monocytes 6.99
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 6.97
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 6.97
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 6.85
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 6.85
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 6.77
Nonpregnant and term pregnant human myometrial tissues 6.77
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 6.65
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 6.65
Leucegene: AML sequencing (part 6) 6.62
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 6.61
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 6.61
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 6.61
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 6.56
Be1 and Be2 B cells are transcriptionally distinct 6.49
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 6.46
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 6.33
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 6.31
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 6.31
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 6.26
Uridylation by TUT4 and TUT7 marks mRNA for degradation 6.23
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 6.07
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 6.07
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 6.03
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 6.02
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 6.02
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 6.01
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 5.96
Age-Related Gene Expression Changes in Prostate Cancer Patients 5.96
Transcriptome analysis reveals differential splicing events in IPF lung tissue 5.81
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.8
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 5.77
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 5.59
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 5.58
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 5.54
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 5.47
Characterization of human ILC2 subsets 5.46
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 5.39
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 5.38
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 5.36
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 5.35
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 5.35
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 5.35
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 5.33
Global epigenomic reconfiguration during mammalian brain development 5.3
RNA-Seq of PRMT1 overexpression ECA109 cells 5.25
Human ovarian granulosa cell transcriptome 5.2
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 5.17
Expression patterns in chronic thromboembolic pulmonary hypertension 5.12
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 5.07
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 5.06
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 5.02
Modeling Human Cancer-induced Cachexia (Human) 5.02
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 5.01
ADAR1-editing of cellular and measles virus-derived duplex RNA 5.01
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 4.91
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 4.83
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 4.75
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 4.69
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 4.67
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 4.67
RNA-Seq in neutrophils from Antiphospholipid Syndrome 4.61
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 4.59
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 4.59
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 4.49
Molecular analysis of renal cell carcinoma with unclassfied histology 4.49
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 4.48
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 4.46
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 4.35
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 4.35
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 4.35
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 4.29
Gene expression profiling of papillary thyroid cancer from central and invasive regions 4.26
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 4.26
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 4.24
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 4.24
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 4.23
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 4.2
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 4.2
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.19
Capturing the Interactome of Newly Transcribed RNA 4.19
Transcriptional effect of ETV1 knockdown in melanoma cells 4.17
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 4.12
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 4.12
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 4.08
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 4.08
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 4.06
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 4.02
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 4.0
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 4.0
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 3.97
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 3.94
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 3.9
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 3.89
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.8
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 3.77
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 3.66
Multiple sclerosis and EAE 3.64
Human optic chiasm from healthy controls and multiple sclerosis patients 3.64
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 3.53
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 3.5
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 3.46
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 3.44
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 3.41
The DNA methylation landscape of human melanoma 3.36
The DNA methylation landscape of human melanoma [RNA-Seq] 3.36
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 3.33
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 3.31
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 3.3
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 3.29
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 3.24
Dilated cardiomyopathy vs Myocarditis 3.24
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 3.16
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 3.09
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 3.04
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 2.97
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 2.97
Targeted enhancer activation by a subunit of the integrator complex 2.96
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 2.96
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 2.96
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 2.91
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 2.82
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 2.76
Identification of expressed and conserved human non-coding RNAs 2.76
Tpl-2 and MEK small molecule inhibitors 2.75
Tpl-2 small molecule project 2.75
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 2.72
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 2.72
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 2.71
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 2.71
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 2.71
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 2.6
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 2.58
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 2.56
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 2.55
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 2.54
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 2.51
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 2.51
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 2.51
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 2.51
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 2.45
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 2.44
Single cell transcriptome of peritoneal cells 2.38
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 2.37
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 2.34
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 2.31
RNA expression profiles comparing primary and omental ovarian carcinoma samples 2.3
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 2.3
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 2.28
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 2.24
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.23
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 2.22
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 2.21
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.1
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.1
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 2.03
Transcriptome analysis of human lung epithelial cells 1.94
Role of cervicovaginal microbiota in genital inflammation 1.89
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.86
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.86
4sUDRB-seq: measuring transcription elongation and initiation genomewide 1.85
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.84
Transcriptomic analysis of human macrophages in 3D 1.83
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.82
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 1.78
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 1.74
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.67
Specific molecular signatures underlie response to decitabine in CMML 1.65
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 1.65
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 1.59
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.57
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 1.54
RNA-Seq of the corpus callosum from 12 individuals 1.5
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.46
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 1.44
Human Treg IFNg/IL-10 subpopulations 1.35
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 1.3
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.28
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 1.23
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 1.14
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 1.07
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 1.06
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.04
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 1.03
Leucegene: ALL sequencing 1.02
RNA sequencing of T-ALL (COG study) 1.0
Analyses of T-ALL (COG study) 1.0
The gene expression profiles of gallbladder cancer 1.0
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.98
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.97
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.97
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.96
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 0.86
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 0.84
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 0.84
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.74
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 0.72
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 0.65
The human blood-nerve barrier transcriptome 0.6
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.6
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.6
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.58
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 0.57
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 0.57
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.53
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.53
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.5
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.48
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.45
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.29
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.28
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.26
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 0.22
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.21
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.18
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.14
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.14
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.12
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 0.12
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.02
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation